As of 2025-05-21, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is -2.72 USD. This Anavex valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.53 USD, the upside of Anavex Life Sciences Corp is -136.16%.
Based on its market price of 7.53 USD and our intrinsic valuation, Anavex Life Sciences Corp (AVXL) is overvalued by 136.16%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.72 - -2.72 | -2.72 | -136.16% |
| P/E | (5.02) - (10.26) | (8.20) | -208.8% |
| DDM - Stable | (3.34) - (8.41) | (5.87) | -178.0% |
| DDM - Multi | (0.87) - (1.73) | (1.16) | -115.4% |
| Market Cap (mil) | 642.84 |
| Beta | 1.36 |
| Outstanding shares (mil) | 85.37 |
| Enterprise Value (mil) | 522.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.62% |
| Cost of Debt | 5.00% |
| WACC | 8.81% |